Free-cash-flow margin moved 661 bp lower
Free-cash-flow margin changed -661 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
13.42%→6.81%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →TOST financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash-flow margin moved 684 bp lower
Operating cash-flow margin changed -684 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
14.39%→7.55%2 prior comparisons
Cost of revenue increased 20.2%
Cost of revenue changed +20.2% from the comparable as-filed period.
$1.2B→$1.4B2 prior comparisons
Cash & equivalents decreased 15.0%
Cash & equivalents changed -15.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$1.2B→$1.0B2 prior comparisons
Operating cash flow / net income decreased 66.5%
Operating cash flow / net income changed -66.5% from the comparable as-filed period.
2.79→0.941 prior comparisons
Total assets increased 15.0%
Total assets changed +15.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$2.8B→$3.2B4 prior comparisons
Current assets increased 14.4%
Current assets changed +14.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$2.3B→$2.7B4 prior comparisons
Trade receivables increased 17.4%
Trade receivables changed +17.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$121.0M→$142.0M4 prior comparisons
Research & development increased 19.8%
Research & development changed +19.8% from the comparable as-filed period.
$91.0M→$109.0M2 prior comparisons
SBC / revenue moved 99 bp lower
SBC / revenue changed -99 basis points from the comparable as-filed period.
3.87%→2.88%2 prior comparisons
Current ratio decreased 7.4%
Current ratio changed -7.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
2.59→2.44 prior comparisons
Working capital increased 8.6%
Working capital changed +8.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.4B→$1.5B4 prior comparisons
Capex / revenue moved 23 bp lower
Capex / revenue changed -23 basis points from the comparable as-filed period.
0.97%→0.73%2 prior comparisons
Stock-based compensation decreased 8.3%
Stock-based compensation changed -8.3% from the comparable as-filed period.
$60.0M→$55.0M2 prior comparisons
R&D / revenue moved 16 bp lower
R&D / revenue changed -16 basis points from the comparable as-filed period.
5.87%→5.71%2 prior comparisons
Capital expenditure decreased 6.7%
Capital expenditure changed -6.7% from the comparable as-filed period.
$15.0M→$14.0M3 prior comparisons
Receivables / revenue moved 36 bp lower
Receivables / revenue changed -36 basis points from the comparable as-filed period.
7.81%→7.44%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.